Bioactive peptides play a crucial role in various physiological processes and provide various health benefits such as increased muscle mass, improved cardiovascular health, lower inflammation, and enhanced cognitive functions. These peptides are increasingly finding wide applications in functional foods, clinical nutrition, sports nutrition, and pharmaceutical formulations due to their therapeutic properties.
The global Bioactive Peptide Market is estimated to be valued at US$ 11.29 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Bioactive peptides help to enhance athletic performance, build muscle mass, reduce inflammation, improve glucose metabolism, and support cognitive functions. As consumers are increasingly health conscious and focus on preventive healthcare, the demand for nutraceuticals containing bioactive peptides is rising. This is encouraging manufacturers to develop innovative products containing bioactive peptides for various health applications. For instance, milk-derived bioactive peptides are widely used in functional dairy products for their anti-hypertensive properties.
SWOT Analysis
Strength: Bioactive peptides possess various beneficial properties including antioxidant, antihypertensive, antimicrobial, and immunomodulatory attributes. This makes them suitable ingredients for nutraceuticals, functional foods, and cosmeceuticals.
Weakness: High production costs associated with developing and producing novel bioactive peptides limit their widespread use. Research into isolating novel peptides from waste streams can help address this challenge.
Opportunity: Growing consumer awareness about the health benefits of bioactive peptides is driving demand for peptide-enriched foods and supplements. The opportunities lie in developing affordable delivery formats and innovative applications.
Threats: Stringent regulatory frameworks for novel ingredients. Potential threats from substitute ingredients that provide similar functionalities at lower costs.
Key Takeaways
The Global Bioactive Peptide Market Size  is expected to witness high growth over the forecast period. Rapid adoption of healthy, nutrient-rich diets supports the use of bioactive peptides across industries.
Regional analysis: North America currently dominates the market owing to high health awareness and expenditure on nutraceuticals. However, Asia Pacific is emerging as the fastest growing market for bioactive peptides driven by growing middle-class populations and their willingness to pay premium prices for functional ingredients.
Key players: Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Kerry Group, Cargill, Incorporated, DSM, Corbion NV, Saputo Ingredients, Fonterra Co-operative Group Ltd, Frieslandcampina, Arla Foods, and APC Inc. These players are engaged in expanding their product portfolios and regional presence through collaborations with local players.
For More details on the topic:
Check more trending articles related to this topic:
